Atyr Pharma INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NASDAQ
aTyr Pharma sets date for its annual stockholder meeting and outlines key proposals for vote, including director elections and executive compensation.
NASDAQ
aTyr Pharma's upcoming annual meeting on May 1, 2025, will address key corporate governance matters, including the election of directors, ratification of the auditor, executive compensation, and an amendment to the stock option plan.
NASDAQ
aTyr Pharma will hold its annual meeting of stockholders on May 22, 2024, to vote on director elections, auditor ratification, executive compensation, and an amendment to the stock option plan.
NASDAQ
aTyr Pharma announces its 2024 Annual Meeting of Stockholders to be held on May 22, 2024, featuring proposals including director elections, auditor ratification, executive compensation, and stock plan amendments.